Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$34.2M Buy
740,210
+96,467
+15% +$3.89M 0.05% 171
2026
Q1
$21.3M Buy
+643,743
New +$20.9M 0.06% 191
2022
Q1
Sell
-435,527
Closed -$4.08M 393
2021
Q4
$4.08M Sell
435,527
-200,000
-31% -$2.4M 0.01% 323
2021
Q3
$10M Buy
635,527
+55,443
+10% +$996K 0.02% 302
2021
Q2
$12.5M Hold
580,084
0.03% 286
2021
Q1
$11.8M Buy
580,084
+75,000
+15% +$1.48M 0.03% 280
2020
Q4
$9.04M Hold
505,084
0.02% 274
2020
Q3
$5.87M Hold
505,084
0.02% 269
2020
Q2
$4.67M Hold
505,084
0.02% 255
2020
Q1
$5.25M Buy
505,084
+80,000
+19% +$1.02M 0.03% 237
2019
Q4
$7.61M Hold
425,084
0.03% 236
2019
Q3
$5.3M Buy
425,084
+175,000
+70% +$2.88M 0.02% 247
2019
Q2
$4.95M Sell
250,084
-1,302
-0.5% -$27.9K 0.02% 263
2019
Q1
$5.29M Buy
251,386
+140,676
+127% +$2.57M 0.02% 252
2018
Q4
$2.26M Sell
110,710
-29,817
-21% -$933K 0.01% 282
2018
Q3
$5.18M Buy
140,527
+8,489
+6% +$371K 0.02% 249
2018
Q2
$6.63M Hold
132,038
0.03% 219
2018
Q1
$4.82M Sell
132,038
-88,931
-40% -$2.73M 0.02% 233
2017
Q4
$6.25M Buy
220,969
+43,034
+24% +$1.02M 0.03% 219
2017
Q3
$3.44M Buy
+177,935
New +$2.99M 0.02% 249

Other funds holding AXGN

BAMCO Inc's AXGN Position: Q2 2026 in Review

BAMCO Inc increased its Axogen (AXGN) stake by 15% in Q2 2026, buying an estimated $3.89M and bringing the position to 740,210 shares worth $34.2M. The position accounts for 0.05% of the portfolio, ranked #171.

BAMCO Inc first reported a position in AXGN in Q3 2017 and has held it in 20 quarters since. 253 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.

  • BAMCO Inc held 740,210 shares of Axogen worth $34.2M as of Q2 2026.
  • BAMCO Inc bought 96,467 Axogen shares in Q2 2026, an estimated $3.89M.
  • Axogen made up 0.05% of BAMCO Inc's portfolio in Q2 2026, its #171 holding.
  • BAMCO Inc first reported a position in Axogen in Q3 2017 and has held it in 20 quarters since.
  • 253 funds tracked by Wall St. Rank held Axogen as of Q2 2026.

Based on BAMCO Inc's 13F filing for Q2 2026, filed 14 Aug 2026.